Biotech Values

[mcbio]

it certainly doesnt seem like ribavirin will be needed when the phase 3 data come out in this subtype

May not in GT1b as that seems to be the lowest-hanging fruit in the HCV space. Presumably need more data to answer this question in cirrhotic patients though.